Fatty acid amide hydrolase (FAAH) breaks down anandamide. However, CBD inhibits the FAAH enzyme, which means the bliss molecule remains active in the ECS for longer; thus enhancing its potency.
Those who suffer from chronic pain are using CBD in the belief that the cannabinoid can help manage the symptoms. CBD modifies CB2 receptors’ ability to bind endocannabinoids. Alternatively, it may cause the body to produce more of the natural cannabinoids that attach to the CB2 receptors.
CBD’s antipsychotic effects relate to its impact on anandamide. Scientists link higher levels of the bliss molecule with a decrease in psychotic symptoms. A study by Leweke et al. published in Translational Psychiatry in March 2012, looked into the effect of CBD on anandamide production.
4 – CBD Lowers the Degree of Excitation in Brain Cells
When you consume cannabis, the plant’s cannabinoids bind to the receptors in a manner akin to a key fitting into a lock. The receptors that are affected and parts of the brain that get involved vary from person to person depending on factors such as previous drug use and genetic make-up.
THC, the cannabinoid associated with a psychotropic high, is intoxicating — CBD is not.
Glutamine-dependent excitotoxicity is seen in practically every age-related neurodegenerative disease and brain disorder. It also happens to be one of the main molecular mechanisms noted in epilepsy. In recent times, there has been an increasing level of research into CBD as a treatment for neurodevelopmental disorders such as autism spectrum disorder (ASD).
THC closely mimics a naturally occurring cannabinoid named anandamide which binds to the CB1 receptors, which are responsible for many of THC’s psychoactive effects. As the psychoactive cannabinoid binds to anandamide’s CB1 receptors even more closely than anandamide, which is known as ‘the bliss molecule.’ It inhibits the release of other neurotransmitters. This helps explain the feelings of euphoria associated with the ‘high’ from cannabis.
CBD has long been praised for its anti-anxiety effects. Actually, this is the number one reason why people use CBD oil. When you scan the Internet for positive voices of Cannabidiol, you will come across a sea of success stories of patients that managed to go cold turkey on their drug cocktails thanks to CBD.
A 2016 study published in the Frontiers of Pharmacology showed that CBD on the brain inhibits the breakdown of anandamide , which boosts endocannabinoid levels on the brain’s synapses. Anandamide is often called the human version of marijuana because anandamide and THC are much alike in their chemical structure. They also produce similar effects; anandamide controls mood, pain perception, body temperature, appetite, and more.
1. CBD And The Serotonin System
CBD attaches to vanilloid receptors , also known as TRPV1 receptors, to achieve certain therapeutic effects. Because TRPV1 is an ion channel, it helps the body r egulate its temperature, control inflammation, and change the perception of pain .
While most of the research available today has put its focus on understanding the relationship between humans and THC, CBD on the brain has been recently shown to have great potential with regard to its medical versatility. Once we fully understand all the properties of hemp and marijuana, we will be able to unlock its full power and use it in a way that could benefit us even more than it does now.
Now, let’s sum up some of the most noteworthy therapeutic properties of CBD.
McHaffie JG, Stanford TR, Stein BE, Coizet W, Redgrave P. Subcortical loops through the basal ganglia. Trends Neurosci. 2005;28:401–7.
Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Conn PJ, Battaglia G, Marino MJ, Nicoletti F. Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci. 2005;6:787–98.
Kennedy DP, Courchesne E. Functional abnormalities of the default network during self- and other-reflection in autism. Soc Cogn Affect Neurosci. 2008;3:177–90.
Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M, et al. TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci. 2009;40:89–97.
Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex. 2004;14:1100–9.
Department of Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK